Xenon Pharmaceuticals Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Xenon Pharmaceuticals Inc. (XENE) is 3.56B

According to Xenon Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.56B. This represents a change of -15.69% compared to the average of 4.22B of the last 4 quarters.

Xenon Pharmaceuticals Inc. (XENE) Historical Enterprise Value (quarterly & annually)

How has XENE Enterprise Value performed in the past?

The mean historical Enterprise Value of Xenon Pharmaceuticals Inc. over the last ten years is 1.38B. The current 3.56B Enterprise Value has changed 158.10% with respect to the historical average. Over the past ten years (40 quarters), XENE's Enterprise Value was at its highest in in the June 2026 quarter at 5.90B. The Enterprise Value was at its lowest in in the December 2019 quarter at -8305000.00.

Xenon Pharmaceuticals Inc. (XENE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Xenon Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Xenon Pharmaceuticals Inc. (XENE) Average Enterprise Value

How has XENE Enterprise Value performed in the past?

The current Enterprise Value of Xenon Pharmaceuticals Inc. (XENE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Xenon Pharmaceuticals Inc. (XENE) Enterprise Value vs. Peers

How is XENE’s Enterprise Value compared to its peers?

Xenon Pharmaceuticals Inc.’s Enterprise Value is less than Praxis Precision Medicines, Inc. (7.27B), greater than Rapport Therapeutics, Inc. Common Stock (1.13B), less than Axsome Therapeutics, Inc. (6.75B), less than Neurocrine Biosciences, Inc. (14.85B), greater than Acadia Pharmaceuticals Inc. (3.20B), greater than Denali Therapeutics Inc. (2.82B), greater than Neumora Therapeutics, Inc. Common Stock (-33481591.00), less than Jazz Pharmaceuticals plc (16.75B), greater than Supernus Pharmaceuticals, Inc. (2.30B), greater than Anavex Life Sciences Corp. (-8035297.00),

Build a custom stock screener for Xenon Pharmaceuticals Inc. (XENE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xenon Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xenon Pharmaceuticals Inc. (XENE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xenon Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.